Eosinophils from healthy children (1-3 years) and adults express high levels of prostaglandin D2 receptor 2 (DP2)

V. Erpenbeck (Basel, Switzerland), P. Groh (Cincinnati, United States of America), K. Curtsinger (Cincinnati, United States of America), C. Sarah (Cambridge, United States of America), I. Jones (Basel, Switzerland), S. Machineni (Hyderabad, India), M. Cabanski (Basel, Switzerland), A. Vitaliti (Basel, Switzerland), Y. Pluess-Li (Basel, Switzerland), A. Verles (Basel, Switzerland), B. Dharmalingam (Hyderabad, India), G. Hershey (Cincinnati, United States of America)

Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Session: Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Session type: Thematic Poster
Number: 4456
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Erpenbeck (Basel, Switzerland), P. Groh (Cincinnati, United States of America), K. Curtsinger (Cincinnati, United States of America), C. Sarah (Cambridge, United States of America), I. Jones (Basel, Switzerland), S. Machineni (Hyderabad, India), M. Cabanski (Basel, Switzerland), A. Vitaliti (Basel, Switzerland), Y. Pluess-Li (Basel, Switzerland), A. Verles (Basel, Switzerland), B. Dharmalingam (Hyderabad, India), G. Hershey (Cincinnati, United States of America). Eosinophils from healthy children (1-3 years) and adults express high levels of prostaglandin D2 receptor 2 (DP2). 4456

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: A single/multiple ascending dose (SAD/MAD) phase 1 study
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019


GB001, a selective prostaglandin D2 receptor 2 antagonist, blocks signaling in the peripheral blood of healthy subjects
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020


Glucocorticosteroid receptor (GCR) gene isoforms expression in bronchial asthma (BA) patients
Source: Annual Congress 2011 - Asthma: a heterogeneous disease
Year: 2011


Thromboxane B2 (TXB2) urine levels during long term treatment with montelukast (M) in asthmatic subjects
Source: Eur Respir J 2001; 18: Suppl. 33, 353s
Year: 2001

Prevalence of asthma and atopic states-related symptoms in school (6-7 yrs), high school (13-14 yrs) children in Tabriz (ISAAC study)
Source: Eur Respir J 2001; 18: Suppl. 33, 368s
Year: 2001

Deletion in macrophage chemokine receptor gene (CCR5) in children with bronchial asthma (BA)
Source: Eur Respir J 2001; 18: Suppl. 33, 450s
Year: 2001

High affinity receptor for immunoglobulin E (FcER1-β) gene polymorphisms in Turkish allergic asthmatic subgroups
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009


Expression on peripheral blood (PB) and induced sputum (IS) neutrophils (N) of the IL-8 receptors CXCR1 and CXCR2. Comparison between neutrophilic asthma and COPD
Source: Annual Congress 2003 - From gene to breath analysis in airway disorders
Year: 2003


Expression of glucocorticoid receptor beta (GCRβ) in asthmatic children and its correlation with clinical severity
Source: Eur Respir J 2004; 24: Suppl. 48, 162s
Year: 2004

Mas receptor antagonist inhibits the pro-resolutive effects of Angiotensin-(1-7) in an experimental model of asthma.
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019

Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001

Lung function parameters in healthy Lybian children (aged 4-19 years)
Source: Eur Respir J 2005; 26: Suppl. 49, 612s
Year: 2005

Validation of the asthma control questionnaire in children (6-16 years)
Source: Annual Congress 2009 - Clinical advances in childhood asthma
Year: 2009


Pneumonia severity index (PSI) at young patients and toll-like receptor 4 (TLR4) polymorphism interconnections: new diagnostic approach
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019


Does beta2 adrenoceptor (ADRβ2) density vary in circulating lymphyocytes compared with monocytes?
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011


Distinct effects of the endothelin receptor antagonists PD 142893 (ET-A/B), BQ 788 (ET-B) and N-Ac-Trp-ET 1 Frg. 16-21 (ET-A) on oxidative stress-induced pulmonary hypertension in isolated rabbit lungs
Source: Eur Respir J 2001; 18: Suppl. 33, 198s
Year: 2001

Cytokines and alpha-1proteinase inhibitor (A1 PI) levels in meat wrappers‘ asthma
Source: Annual Congress 2010 - Occupational asthma
Year: 2010

Diagnostic value of serum soluble interleukin-2 receptor (SIL- 2R) and acute phase proteins levels (APP) in community acquired pneumonia
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003

PBF-680, an oral A1 adenosine receptor antagonist, inhibits the late allergic response (LAR) in mild-to-moderate atopic asthmatics: a Phase-IIa trial
Source: Virtual Congress 2020 – Cutting edge science: novel molecules and mechanisms of airway diseases
Year: 2020




Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011